CVS Pharmacy: The Diagnosis Check Behind the Medi-Cal Bill

Whistleblower Justice Network

In the CVS Medi-Cal diagnosis settlement case, CVS Pharmacy paid $18,282,280 to resolve allegations that it billed California’s Medicaid program without the diagnosis support and documentation required for certain Code 1 drugs. The government alleged that CVS certified compliance without doing the necessary checks. For a pharmacist or billing employee, the telling comparison is what the pharmacy knew about the diagnosis when it told Medi-Cal the prescription qualified for payment.

The Justice Department announced the settlement on November 17, 2025. A former CVS pharmacist brought the qui tam whistleblower case included in the resolution. Medi-Cal, administered by the California Department of Health Care Services, uses federal and state money to provide health care to Californians, including people with low incomes and disabilities. The diagnosis requirement helped determine which prescriptions that public money would cover. On the government’s account, money meant for those Californians paid for prescriptions CVS had not confirmed met the program’s diagnosis requirements.

What Did Medi-Cal Code 1 Certification Require?

Medi-Cal Code 1 certification required the pharmacy to confirm that a restricted drug was being dispensed for an approved diagnosis and to meet the applicable documentation requirements. The pharmacy made a representation about coverage when it sought payment.

Medi-Cal’s formulary, its list of covered drugs and restrictions, limited payment for certain drugs to approved diagnoses. The Justice Department described safety, efficacy, misuse potential and cost as considerations behind those limits. CVS had a gatekeeping responsibility: confirming and certifying that the prescription met the diagnosis restriction.

The settlement agreement addressed alleged electronic certifications from January 1, 2010 through April 30, 2021. The prescription, the clinical support and the certification each had a job to do. We compare what the prescriber supplied with what the pharmacy represented to Medi-Cal.

There was also a route to payment for a prescription outside the approved diagnoses. As the Justice Department explained, CVS could submit a request to the state department with a justification for the nonapproved use. That made the authorization request and decision part of the evidence, alongside the diagnosis records.

For an insider familiar with pharmacy diagnosis certifications, the distinction matters. The coverage restriction sets the requirement, and the clinical records support the diagnosis. The question is which basis the pharmacy relied on when it certified and billed.

What the Government Alleged CVS Failed to Check

The government alleged that CVS failed to confirm and document the required diagnoses and, in some instances, dispensed drugs for nonapproved diagnoses before knowingly billing Medi-Cal. The allegations reached both the support for the diagnosis and the pharmacy’s decision to submit the claim.

Those are concrete questions inside a pharmacy. What diagnosis did the prescriber provide? What documentation reached the pharmacy? Was there an authorization for an exception? What did the electronic certification say about the same prescription? An employee handling those exchanges may know where the clinical record and the billing representation separated.

We see the problem plainly: CVS allegedly gave Medi-Cal an assurance without doing the work behind it. The check was supposed to precede the bill. The pharmacy’s knowledge at that moment is what gives the sequence its significance.

The Records Behind the Electronic Certification

The useful comparison follows the same prescription from the coverage requirement through the prescriber’s response, the certification and the payment. The request for clinical support shows what the pharmacy understood it needed. The response shows whether the prescriber supplied the diagnosis the pharmacy later certified.

Timing belongs in that comparison. Information received after a certification tells a different story from information available when the claim went out. A pharmacist may remember the missing diagnosis or the unanswered request. A billing employee may remember the rejection that prompted another submission. Those observations matter alongside the dated exchange of information.

For a prescription outside the approved diagnoses, the justification sent to the state department and its authorization decision show the basis on which payment was sought. The authorization belongs beside the prescription it covered.

A pharmacy’s billing history can include an original submission, a rejection, an override, a reversal and a rebill. The final remittance shows what the pharmacy was paid after those events. When a rejected claim is resubmitted, we compare the paid version with the earlier submission and the clinical information available for each. What changed in the claim, and what support arrived before it was paid?

Pickup or delivery records and any return to stock connect that history to the medicine. They are central in cases involving prescriptions that were never collected, where the handoff to the patient is the disputed event.

Diagnosis Certification and False Prior Authorizations

Diagnosis certification concerns the support for the pharmacy’s representation that a prescription meets coverage requirements. False prior authorizations can also involve pharmacy staff supplying answers as though they came from the physician’s office.

Solera Specialty Pharmacy illustrates that separate practice. According to the Justice Department’s account of Solera’s deferred prosecution agreement, the company admitted that staff completed Evzio authorizations in physicians’ place, sometimes signed without permission, substituted pharmacy contact details and submitted false clinical information. Those admissions came from the criminal agreement.

In the CVS case, the government challenged the pharmacy’s confirmation and documentation of the diagnosis. In Solera, the origin of the answers and the authority behind the signature were themselves part of the admitted conduct. For a healthcare employee who handles authorizations, knowing who supplied an answer can be as important as knowing what the answer said. We examine both when connecting a coverage request to a paid claim.

What the CVS Settlement Resolved

The CVS settlement resolved allegations that CVS submitted unsupported Medi-Cal claims in violation of the federal and California False Claims Acts. The Justice Department reported payment to both the United States and California. The United States Attorney’s Office for the Eastern District of California worked with California officials on the settlement, with assistance from the Department of Health and Human Services Office of Inspector General and the FBI.

The Inspector General’s office made a pointed observation about oversight:

Although CVS entered into a health care fraud settlement with the United States, CVS did not agree to compliance-related oversight with HHS-OIG through a corporate integrity agreement.

HHS-OIG, quoted in the Justice Department’s CVS settlement announcement, November 17, 2025

The Justice Department described a chain with more than 1,000 California stores. We find that a remarkable bargain: settle allegations of skipped checks without agreeing to HHS-OIG compliance oversight.

The Pharmacist’s Whistleblower Reward

The Justice Department said the former CVS pharmacist would receive approximately $3.3 million of the recovery proceeds. A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.

The pharmacist’s role matters because the disputed certification sat where clinical information became a claim for payment. Someone working at that handoff may understand what the pharmacy received, what remained unanswered and what it submitted anyway. We build the case with that knowledge, connecting the supporting records to the representation and the money.

You Know What Supported the Diagnosis

If you handled the clinical requests or billing and know what supported a Medi-Cal certification, speak to one of our Whistleblower Experts about what you saw. We build your strongest case with you and bring in pharmacy fraud whistleblower lawyers who understand diagnosis and authorization disputes. From the first conversation about an unsupported certification through the pursuit of a recovery, we stay beside you.

WHISTLEBLOWER JUSTICE NETWORK CAN HELP YOU
Make a difference.
Whistleblower Justice NetworkReport Fraud
100% CONFIDENTIALFREE CONSULTATION24 / 7 / 365